Calumet Specialty Products Completes Successful Notes Offering

Calumet Specialty Products Partners, L.P. has successfully completed a notes offering, retiring its senior secured first lien notes due in 2024 and calling $50 million of senior notes due in 2025. The partnership closed $200 million in aggregate principal amount of a new series of 9.25% senior secured first lien notes due in 2029 in a private placement transaction, which were issued at par for proceeds of $200 million.

The net proceeds from the private placement were used to redeem all of the issuers’ outstanding 9.25% senior secured first lien notes due in 2024. Additionally, the partnership intends to use the remaining net proceeds, along with cash on hand, to redeem $50 million in aggregate principal amount of the issuers’ outstanding 11.00% senior notes due in 2025.

Todd Borgmann, the CEO, expressed satisfaction with the transaction, stating, "We were pleased to extend a significant portion of our near-term maturities, reduce our total interest expense, and add flexibility as we execute our deleveraging strategy."

Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. The company is headquartered in Indianapolis, Indiana, and operates twelve facilities throughout North America.

The market has reacted to these announcements by moving the company's shares -0.3% to a price of $14.76. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.